4.6 Article

Endothelial Microparticles Derived from Primary Pulmonary Microvascular Endothelial Cells Mediate Lung Inflammation in Chronic Obstructive Pulmonary Disease by Transferring microRNA-126

Journal

JOURNAL OF INFLAMMATION RESEARCH
Volume 15, Issue -, Pages 1399-1411

Publisher

DOVE MEDICAL PRESS LTD
DOI: 10.2147/JIR.S349818

Keywords

chronic obstructive pulmonary disease; endothelial microparticles; primary pulmonary microvascular endothelial cell; inflammation; microRNA-126

Categories

Funding

  1. National Natural Science Foundation of China [81873410, 81800043, 82070049]
  2. Natural Science Foundation of Hunan Province [2020JJ5818]

Ask authors/readers for more resources

This study reveals that endothelial microparticles (EMPs) derived from primary pulmonary microvascular endothelial cells can alleviate lung inflammation in COPD, and transferring microRNA-126 (miR-126) can magnify the anti-inflammatory effect of EMPs.
Background: Extracellular vesicles (EVs) are considered to new types of intercellular communication media, and microRNA is one of the most common transferring components of EVs. This study aimed to explore the potential role of endothelial microparticles (EMPs) derived from primary pulmonary microvascular endothelial cells in regulating lung inflammation of chronic obstructive pulmonary disease (COPD) through transferring microRNA-126 (miR-126). Methods: EMPs generated from primary pulmonary microvascular endothelial cells were isolated by gradient centrifugation and characterized by transmission electron microscopy, flow cytometry and Western blotting. EMPs were treated to in vitro and in vivo COPD models induced by cigarette smoke extract (CSE). miR-126 mimics or inhibitors were transfected into EMPs by calcium chloride. Pathological changes of lung tissue, mRNA and protein levels of inflammation-related factors were measured to explore the effect of EMPs transferring miR-126 on CSE-induced inflammation. Results: Both in vitro and in vivo studies demonstrated that mRNA and protein levels of inflammation-related factors were significantly increased in COPD group, while EMPs could dramatically reverse these increases. In vitro, overexpression of miR126 in EMPs decreased HMGB1 expression and magnified the decreasing effect of EMPs on inflammation-related factors. Conclusion: The present study reveals that EMPs are capable of alleviating lung inflammation and transferring miR-126 can magnify the anti-inflammatory effect of EMPs, which may provide a novel therapeutic alternative for COPD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available